Human Trappin-2/Elafin Antibody, R&D Systems™

Trappin-2/Elafin/Skalp

Monoclonal

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

cementoin, Elafin, Elastase-specific inhibitor, ESI, ESIWAP four-disulfide core domain protein 14, Peptidase inhibitor 3, peptidase inhibitor 3, skin-derived, PI3, PI-3, pre-elafin, protease inhibitor 3, skin-derived (SKALP), Protease inhibitor WAP3, SKALP, SKALPELAFIN, Skin-derived antileukoproteinase, trappin-2, Trappin2, WAP four-disulfide core domain 14, WAP3MGC13613, WFDC14elafin

Mouse

Protein A or G purified from hybridoma culture supernatant

RUO

5266

Reconstitute at 0.5 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG1

Western Blot

257729

Western Blot 1 ug/mL

P19957

PI3

Mouse myeloma cell line NS0-derived recombinant human Trappin-2/Elafin Ala23-Gln117 Accession # P19957

25 μg

Primary

Detects the full length form (amino acids 23-117) and the trypsin-processed form (amino acids 61-117) of human Trappin-2/Elafin in direct ELISAs and Western blots. In direct ELISAs, no cross-reactivity with recombinant human SLPI is observed.

Human

Purified